Arkolith/Insider Trading/CDTX/Form 4

Shah Preetam

CFO & CBOCidara Therapeutics, Inc. (CDTX) · full profile →Form 4 · filed Mar 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2024Sell(S)19K$0.67$13K227K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610618-24-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML